Patents by Inventor Xujing Tang

Xujing Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING
    Publication number: 20240182446
    Abstract: A TYK2 inhibitor compound containing a bicyclic ring and the use thereof in the preparation of a drug for treating or preventing TYK2-related diseases.
    Type: Application
    Filed: January 30, 2022
    Publication date: June 6, 2024
    Inventors: Fei Liu, Yanlong Liu, Bin Wang, Hongjiang Xu, Xujing Tang
  • METHYL- AND TRIFLUOROMETHYL-CONTAINING DISUBSTITUTED SULFONAMIDE SELECTIVE BCL-2 INHIBITOR
    Publication number: 20220220110
    Abstract: Disclosed is a methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor; specifically disclosed are a compound of formula I, a stereoisomer or pharmaceutically acceptable salt of same, a preparation method therefor, and a pharmaceutical composition comprising the compound. Also disclosed are uses of the compound and of the pharmaceutical composition comprising the compound in treating anti-apoptotic protein BCL-2-related diseases such as cancer.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 14, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Fei LIU, Yanlong LIU, Hongjiang XU, Xiquan ZHANG, Shanchun WANG, Jianqing ZHANG, Weiwei FENG, Bin WANG, Jinan WANG, Yubing WANG, Xujing TANG, Quandeng NIE
  • TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR
    Publication number: 20220002290
    Abstract: Disclosed is a trifluoromethyl-substituted sulfonamide BCL-2-selective inhibitor, in particular disclosed are a compound of formula I, a stereoisomer or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition thereof. Also disclosed are the uses of said compound and of a pharmaceutical composition comprising same for treating anti-apoptotic BCL-2-related diseases, such as cancer.
    Type: Application
    Filed: October 29, 2019
    Publication date: January 6, 2022
    Inventors: Fei Liu, Weiwei Feng, Bin Wang, Hongjiang Xu, Jinan Wang, Xiquan Zhang, Shanchun Wang, Yanlong Liu, Jianqing Zhang, Yiyan Yao, Xujing Tang, Wei Shi, Hongying Zhang, Yang Li, Song Tang, Yizhong Zhu, Limin Liu, Hongmei Gu, Ling Yang